Seeking AlphaMon, 30 Mar 2026 20:04:48 GMTCastle Biosciences: Buying The Remaining DecisionDx-Melanoma UpsideCSTL+1.03%
Seeking AlphaTue, 24 Mar 2026 01:13:39 GMTCastle Biosciences, Inc. (CSTL) Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study TranscriptCSTL+1.03%
Seeking AlphaFri, 27 Feb 2026 01:57:54 GMTCastle Biosciences, Inc. (CSTL) Q4 2025 Earnings Call TranscriptCSTL+1.03%
Zacks Investment ResearchFri, 27 Feb 2026 00:01:36 GMTCastle Biosciences, Inc. (CSTL) Reports Q4 Loss, Beats Revenue EstimatesCSTL+1.03%
Zacks Investment ResearchThu, 19 Feb 2026 16:01:03 GMTCastle Biosciences, Inc. (CSTL) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseCSTL+1.03%
Zacks Investment ResearchMon, 09 Feb 2026 15:36:21 GMTCastle Biosciences (CSTL) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerCSTL+1.03%
Zacks Investment ResearchFri, 23 Jan 2026 18:01:08 GMTAre You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great ChoiceCSTL+1.03%
